Our Medicines

To contact Medical Information about our products or report an adverse event, click here.

 

Focusing on the health of Canadians

Takeda’s top priority is the health of Canadians. Their well-being is central to our work and drives our commitment to deliver a diverse portfolio of innovative treatments.


Current important medicines available to Canadians from Takeda Canada include:

PRODUCTS

 

ALUNBRIG

brigatinib

Product Monograph

DEXILANT®

dexlansoprazole

Product Monograph 

ENTYVIO®

vedolizumab

Product Monograph

KAZANO®

alogliptin (as alogliptin benzoate) and metformin hydrochloride

Product Monograph

NESINA®

alogliptin (as alogliptin benzoate)

Product Monograph

NINLARO®

ixazomib (as ixazomib citrate)

Product Monograph

ONDISSOLVE®

ondansetron

Product Monograph

PANTOLOC®

pantoprazole sodium

Product Monograph

TACHOSIL®

Absorbable fibrin sealant patch

Product Monograph

TECTA®

pantoprazole magnesium

Product Monograph

ULORIC®

febuxostat

Product Monograph 
 
ALUNBRIG™ is a trademark of ARIAD Pharmaceuticals, Inc. and used under license by Takeda Canada Inc.
DEXILANT® is a trademark of Takeda Pharmaceuticals U.S.A., Inc and used under licence by Takeda Canada Inc.
ENTYVIO® is a registered trademark of Millennium Pharmaceuticals, Inc. and used under licence by Takeda Canada Inc.
KAZANO® is a trademark of Takeda Pharmaceutical Company Limited and used under license by Takeda Canada Inc.
NESINA® is a registered trademark of Takeda Pharmaceutical Company Limited and used under license by Takeda Canada Inc.

NINLARO® is a registered trademark of Millennium Pharmaceuticals, Inc. and used under licence by Takeda Canada Inc.

ONDISSOLVE® is a registered trademark of Takeda GmbH. Used under license.
PANTOLOC® and TECTA® are registered trademarks of Takeda GmbH. Used under licence.
TACHOSIL® is a registered trademark of Takeda Pharma AS. Used under licence.
ULORIC® is a registered trademark of Takeda Pharmaceuticals U.S.A., Inc. and used under licence by Takeda Canada Inc.